Pharmacokinetic properties and bioequivalence of gefitinib 250 mg in healthy Korean male subjects.
- Published in:
- Translational & Clinical Pharmacology, 2021, v. 29, n. 3, p. 171, doi. 10.12793/tcp.2021.29.e17
- By:
- Publication type:
- Article
Works matching IS 2289-0882 AND VI 29 AND IP 3 AND DT 2021
Results: 6
1
2
The possibility of low isomerization of ß-lapachone in the human body.
- Published in:
- Translational & Clinical Pharmacology, 2021, v. 29, n. 3, p. 160, doi. 10.12793/tcp.2021.29.e16
- By:
- Publication type:
- Article
3
Comparison of the pharmacokinetics and pharmacodynamics of YH4808 in healthy subjects for defining an appropriate dosing regimen.
- Published in:
- Translational & Clinical Pharmacology, 2021, v. 29, n. 3, p. 150, doi. 10.12793/tcp.2021.29.e15
- By:
- Publication type:
- Article
4
Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform.
- Published in:
- Translational & Clinical Pharmacology, 2021, v. 29, n. 3, p. 135, doi. 10.12793/tcp.2021.29.e14
- By:
- Publication type:
- Article
5
Validation of LC-MS/MS method for determination of rosuvastatin concentration in human blood collected by volumetric absorptive microsampling (VAMS).
- Published in:
- Translational & Clinical Pharmacology, 2021, v. 29, n. 3, p. 125, doi. 10.12793/tcp.2021.29.e13
- By:
- Publication type:
- Article
6
The use of real-world data in drug repurposing.
- Published in:
- Translational & Clinical Pharmacology, 2021, v. 29, n. 3, p. 117, doi. 10.12793/tcp.2021.29.e18
- By:
- Publication type:
- Article